Back to Report Store Home

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

  • Published: Sep-2018
  • Report Code: GBIHC045IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Post-Traumatic Stress Disorder (PTSD)

Table 2: Number of Products under Development by Companies, Post-Traumatic Stress Disorder (PTSD)

Table 3: Number of Products under Development by Universities/Institutes, Post-Traumatic Stress Disorder (PTSD)

Table 4: Products under Development by Companies, Post-Traumatic Stress Disorder (PTSD)

Table 5: Products under Development by Universities/Institutes, Post-Traumatic Stress Disorder (PTSD)

Table 6: Number of Products under Development for Obsessive-Compulsive Disorder

Table 7: Number of Products under Development by Companies, Obsessive-Compulsive Disorder

Table 8: Number of Products under Development by Universities/Institutes, Obsessive-Compulsive Disorder

Table 9: Products under Development by Companies, Obsessive-Compulsive Disorder

Table 10: Products under Development by Universities/Institutes, Obsessive-Compulsive Disorder

Table 11: Number of Products under Development for Depression

Table 12: Number of Products under Development by Companies, Depression

Table 13: Number of Products under Development by Universities/Institutes, Depression

Table 14: Products under Development by Companies, Depression

Table 15: Products under Development by Universities/Institutes, Depression

Table 16: Number of Products by Stage and Target, Post-Traumatic Stress Disorder (PTSD)

Table 17: Number of Products by Stage and Mechanism of Action, Post-Traumatic Stress Disorder (PTSD)

Table 18: Number of Products by Stage and Route of Administration, Post-Traumatic Stress Disorder (PTSD)

Table 19: Number of Products by Stage and Molecule Type, Post-Traumatic Stress Disorder (PTSD)

Table 20: Number of Products by Stage and Target, Obsessive-Compulsive Disorder

Table 21: Number of Products by Stage and Mechanism of Action, Obsessive-Compulsive Disorder

Table 22: Number of Products by Stage and Route of Administration, Obsessive-Compulsive Disorder

Table 23: Number of Products by Stage and Molecule Type, Obsessive-Compulsive Disorder

Table 24: Number of Products by Stage and Target, Depression

Table 25: Number of Products by Stage and Mechanism of Action, Depression

Table 26: Number of Products by Stage and Route of Administration, Depression

Table 27: Number of Products by Stage and Molecule Type, Depression

Table 28: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Actinogen Medical Ltd

Table 29: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Addex Therapeutics Ltd

Table 30: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Amorsa Therapeutics Inc

Table 31: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Aptinyx Inc

Table 32: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Azevan Pharmaceuticals Inc

Table 33: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Bionomics Ltd

Table 34: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Catalyst Pharmaceuticals Inc

Table 35: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Chronos Therapeutics Ltd

Table 36: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Corcept Therapeutics Inc

Table 37: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Eli Lilly and Co

Table 38: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Embera NeuroTherapeutics Inc

Table 39: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Immodulon Therapeutics Ltd

Table 40: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Johnson & Johnson

Table 41: Post-Traumatic Stress Disorder (PTSD) – Pipeline by NeuroNascent Inc

Table 42: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Omeros Corp

Table 43: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Otsuka Holdings Co Ltd

Table 44: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Pragma Therapeutics SAS

Table 45: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Sanofi

Table 46: Post-Traumatic Stress Disorder (PTSD) – Pipeline by SpringWorks Therapeutics LLC

Table 47: Post-Traumatic Stress Disorder (PTSD) – Pipeline by Tonix Pharmaceuticals Holding Corp

Table 48: Obsessive-Compulsive Disorder – Pipeline by Addex Therapeutics Ltd

Table 49: Obsessive-Compulsive Disorder – Pipeline by Amorsa Therapeutics Inc

Table 50: Obsessive-Compulsive Disorder – Pipeline by Biohaven Pharmaceutical Holding Company Ltd

Table 51: Obsessive-Compulsive Disorder – Pipeline by Omeros Corp

Table 52: Depression – Pipeline by Acadia Pharmaceuticals Inc

Table 53: Depression – Pipeline by Ache Laboratorios Farmaceuticos SA

Table 54: Depression – Pipeline by Adamed Sp z oo

Table 55: Depression – Pipeline by Addex Therapeutics Ltd

Table 56: Depression – Pipeline by Aequus Pharmaceuticals Inc

Table 57: Depression – Pipeline by Albany Molecular Research Inc

Table 58: Depression – Pipeline by Alkermes Plc

Table 59: Depression – Pipeline by Allergan Plc

Table 60: Depression – Pipeline by Amorsa Therapeutics Inc

Table 61: Depression – Pipeline by Anavex Life Sciences Corp

Table 62: Depression – Pipeline by Avanir Pharmaceuticals Inc

Table 63: Depression – Pipeline by Axsome Therapeutics Inc

Table 64: Depression – Pipeline by Azevan Pharmaceuticals Inc

Table 65: Depression – Pipeline by BioCrea GmbH

Table 66: Depression – Pipeline by Bionomics Ltd

Table 67: Depression – Pipeline by BioXcel Therapeutics Inc

Table 68: Depression – Pipeline by Blackthorn Therapeutics Inc

Table 69: Depression – Pipeline by Boehringer Ingelheim GmbH

Table 70: Depression – Pipeline by Bristol-Myers Squibb Co

Table 71: Depression – Pipeline by Calico LLC

Table 72: Depression – Pipeline by Celgene Corp

Table 73: Depression – Pipeline by Cellix Bio Pvt Ltd

Table 74: Depression – Pipeline by Celon Pharma SA

Table 75: Depression – Pipeline by Cerecor Inc

Table 76: Depression – Pipeline by Clera Inc

Table 77: Depression – Pipeline by Delpor Inc

Table 78: Depression – Pipeline by DURECT Corp

Table 79: Depression – Pipeline by Eisai Co Ltd

Table 80: Depression – Pipeline by Eli Lilly and Co

Table 81: Depression – Pipeline by Fabre-Kramer Pharmaceuticals Inc

Table 82: Depression – Pipeline by FPRT Bio Inc

Table 83: Depression – Pipeline by GlaxoSmithKline Plc

Table 84: Depression – Pipeline by GliaCure Inc

Table 85: Depression – Pipeline by H. Lundbeck AS

Table 86: Depression – Pipeline by Heptares Therapeutics Ltd

Table 87: Depression – Pipeline by Impel NeuroPharma Inc

Table 88: Depression – Pipeline by Intas Pharmaceuticals Ltd

Table 89: Depression – Pipeline by IntelGenx Corp

Table 90: Depression – Pipeline by Intra-Cellular Therapies Inc

Table 91: Depression – Pipeline by Jiangsu Nhwa Pharmaceutical Corp Ltd

Table 92: Depression – Pipeline by Johnson & Johnson

Table 93: Depression – Pipeline by Karuna Pharmaceuticals Inc

Table 94: Depression – Pipeline by KemPharm Inc

Table 95: Depression – Pipeline by Kissei Pharmaceutical Co Ltd

Table 96: Depression – Pipeline by Lead Discovery Center GmbH

Table 97: Depression – Pipeline by Les Laboratoires Servier SAS

Table 98: Depression – Pipeline by Lixte Biotechnology Holdings Inc

Table 99: Depression – Pipeline by Luye Pharma Group Ltd

Table 100: Depression – Pipeline by Mapi Pharma Ltd

Table 101: Depression – Pipeline by Mapreg SAS

Table 102: Depression – Pipeline by MedinCell SA

Table 103: Depression – Pipeline by Medlab Clinical Ltd

Table 104: Depression – Pipeline by Meta-IQ ApS

Table 105: Depression – Pipeline by Mitsubishi Tanabe Pharma Corp

Table 106: Depression – Pipeline by Navitor Pharmaceuticals Inc

Table 107: Depression – Pipeline by Neuralstem Inc

Table 108: Depression – Pipeline by Neurocrine Biosciences Inc

Table 109: Depression – Pipeline by NeuroNascent Inc

Table 110: Depression – Pipeline by Nippon Chemiphar Co Ltd

Table 111: Depression – Pipeline by Novartis AG

Table 112: Depression – Pipeline by Omeros Corp

Table 113: Depression – Pipeline by Otsuka Holdings Co Ltd

Table 114: Depression – Pipeline by Pfizer Inc

Table 115: Depression – Pipeline by Pherin Pharmaceuticals Inc

Table 116: Depression – Pipeline by Protagenic Therapeutics Inc

Table 117: Depression – Pipeline by Relmada Therapeutics Inc

Table 118: Depression – Pipeline by Reviva Pharmaceuticals Inc

Table 119: Depression – Pipeline by Richter Gedeon Nyrt

Table 120: Depression – Pipeline by Sage Therapeutics Inc

Table 121: Depression – Pipeline by Shenox Pharmaceuticals LLC

Table 122: Depression – Pipeline by SK Biopharmaceuticals Co Ltd

Table 123: Depression – Pipeline by Sound Pharmaceuticals Inc

Table 124: Depression – Pipeline by Sumitomo Chemical Co Ltd

Table 125: Depression – Pipeline by Sumitomo Dainippon Pharma Co Ltd

Table 126: Depression – Pipeline by Sunovion Pharmaceuticals Inc

Table 127: Depression – Pipeline by Supernus Pharmaceuticals Inc

Table 128: Depression – Pipeline by Syntropharma Ltd

Table 129: Depression – Pipeline by Taisho Pharmaceutical Holdings Co Ltd

Table 130: Depression – Pipeline by Takeda Pharmaceutical Co Ltd

Table 131: Depression – Pipeline by Trevena Inc

Table 132: Depression – Pipeline by VistaGen Therapeutics Inc

Table 133: Depression – Pipeline by Zysis Ltd

Table 134: Post-Traumatic Stress Disorder (PTSD) – Dormant Projects

Table 135: Obsessive-Compulsive Disorder – Dormant Projects

Table 136: Depression – Dormant Projects

Table 137: Post-Traumatic Stress Disorder (PTSD) – Discontinued Products

Table 138: Obsessive-Compulsive Disorder – Discontinued Products

Table 139: Depression – Discontinued Products

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards